The healthcare private equity firm will buy MatrixCare for $490 million in an all-cash transaction expected to close during the third quarter of 2026.
Source: FierceHealthcare
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.